Clinical Trial Update: Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating systematic empirical versus test-guided anti-tuberculosis treatment in severely immunosuppressed HIV patients starting ART with CD4 <10…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED